HIV and AIDS cure, treatment, and other breakthroughs may be affected by the impending rollback of the National Institutes of Health's budget. President Donald Trump plans to slash the funding for the country's biomedical research.

Securing the definitive HIV and AIDS cure has proven to be challenging and expensive. That is why the funding of the government was expected to be boosted if not maintained to help secure the final solution for HIV/AIDS.

Like Us on Facebook

However, contrary to the ideal plan, Trump wishes to trim the budget of the NIH, suggesting a rollback of its 2018 budget similar to that of the 2003 budget, according to LGBTQ Nation. If it pushes through, this budget cut will affect Fogarty International Center, an organization that focuses on global health including HIV research abroad.

As a result of the drastic changes to be made, Rep. Rosa DeLauro of Connecticut hopes that the US Congress will reject the idea and restore the funding levels for the NIH. He believes that the medical research being made at the NIH will not just save one life, but could ultimately affect millions of lives even generations ahead.

The idea of limiting the budget for a research group like NIH will significantly influence the output of the agency. A cure for HIV and AIDS waiting to be discovered could be delayed as the budget cut will likely affect the workforce of the research institution. HIV/AIDS breakthroughs may not be supplemented with the lack of budget, while promising research may not be realized for the same reason.

In retrospect, there are approximately 36.7 million individuals living with HIV/AIDS worldwide.

Moreover, as of June 2016, 18.2 million people living with HIV were accessing antiretroviral therapy (ART) worldwide. The data above may change for the worse if Trump implements the proposed budget cut for biomedical research.

Watch how HIV affects a human body: